HIROTSUバイオサイエンス | 線虫がん検査に関する世界最先端の線虫行動解析技術

NEWS

Cancer test that uses nematodes N-NOSE® （エヌノーズ）

N-NOSE is a cancer screening test takes advantage of the keen olfactory sensors of nematodes. The test has been available to the public in Japan in January 2020.

N-NOSE service site
Learn More

What is N-NOSE?

Merit of taking a cancer screening test

Why nematodes?

The world's first biological ”diagnostic” technology.

At Hirotsu Bio Science, we contribute to the development of revolutionary disease diagnostic technologies to lessen your concerns over health.

Message from CEO
Learn More

Company Profile

Company History

SDGs
Advisers

News

CEO Hirotsu’s inverview article was in Keizaikai’s “Face”

2020.02.25

CEO Hirotsu’s interview article was in a journal Keizaikai’s “Face”.

For more details→ Link（Japanese only）

More

Peer-reviewed review article on real-world data from the N-NOSE nematode cancer test published in an international scientific journal

The international biomedical journal Biomedicines has just published a peer-reviewed review article* on data showing the effectiveness of N-NOSE . . .

A Great Achievement at EIOC 2024　Selected for “Best Oral Abstract Presenter Award at EIOC 2024

At the Excellence in Oncology Care (EIOC) 2024 conference held in Dubai from October 11 (Fri.) to 13 (Sun.), 2024, our Shonan R&D Center Res . . .

Innovative N-NOSE Showcased at the Excellence in Oncology Care (EIOC 2024) in Dubai, Opening New Opportunities in the Middle East

We, HIROTSU BIO SCIENCE Inc., participated in the Excellence in Oncology Care (EIOC) 2024 conference that was held in Dubai from October 11th (F . . .